Advanced Search

    column
    Advancing Modernization Reform in Pharmaceutical Affairs Management to Catalyze High-Quality Development of Pharmacy Practice
    YANG Yifan, ZHANG Qingsheng, SHAO Rong
    2025, 42(10): 1625-1629. DOI: 10.13748/j.cnki.issn1007-7693.20251493
    Abstract PDF
    Evolution and Deepening of the Concept of Risk Management in the Construction of the Rule of Law System for Drug Regulation
    ZHENG Yujie, YU Xuanrong, LIU Bolin, JIANG Rong, SHAO Rong
    2025, 42(10): 1630-1634. DOI: 10.13748/j.cnki.issn1007-7693.20250461
    CSTR: 未缴费
    Abstract PDF
    Development and Effectiveness of the Generic Drug Review and Approval System in the Context of the Enactment and Amendment of the Drug Administration Law
    YU Yiting, WU Yijia, LIU Bolin, JIANG Rong, SHAO Rong
    2025, 42(10): 1635-1639. DOI: 10.13748/j.cnki.issn1007-7693.20250462
    Abstract PDF
    Study on Necessity and Feasibility of Timely Adjustment Management of Essential Medicine List in China
    LI Ying, SUI Airong, REN Mingrui, SHAO Rong, YAN Jianzhou
    2025, 42(10): 1640-1647. DOI: 10.13748/j.cnki.issn1007-7693.20250453
    CSTR: 免
    Abstract PDF
    Power Relations in Collaborative Drug Safety Governance Networks: Analytical Framework and Comparative Characterization
    WU Lin, CHEN Yongfa
    2025, 42(10): 1648-1656. DOI: 10.13748/j.cnki.issn1007-7693.20250333
    CSTR: 0
    Abstract PDF
    Analysis of the Management Policy of Dispensing and Use of Traditional Chinese Medicine Preparations of Medical Institutions
    DANG Ziyue, ZHOU Jie, ZHANG Yu, FEI Yuda, GUO Dongmei
    2025, 42(10): 1657-1665. DOI: 10.13748/j.cnki.issn1007-7693.20242174
    Abstract PDF
    Research on the Status Quo and Optimization of Provincial Pharmaceutical Reserve Management System in China
    ZHANG Jieying, DU Xueli, FAN Ruixue, MAO Ningying, LI Jun
    2025, 42(10): 1666-1674. DOI: 10.13748/j.cnki.issn1007-7693.20250500
    CSTR: 1
    Abstract PDF
    Analysis of the Current Status of Active Pharmaceutical Ingredient Registration and Management System Challenges in China: An Antitrust Perspective
    HUA Yanzhao, XIE Jinping, SHAO Rong
    2025, 42(10): 1675-1681. DOI: 10.13748/j.cnki.issn1007-7693.20250435
    Abstract PDF
    Analysis and Reflection on Common Issues in Registration Inspection during Drug Registration Review Process
    LIN Juan, QIAO Litao, ZHOU Gang
    2025, 42(10): 1682-1685. DOI: 10.13748/j.cnki.issn1007-7693.20243570
    CSTR: 1
    Abstract PDF
    Changes, Opportunities and Challenges in the Registration and Inspection of Chemical Drugs Produced Overseas in China in the New Era
    LI Wenlong, MEN Yingxuan, WEI Jingjing, WU Zhaoyang, TAN Liyuan, WANG Xuelei, SHI Jia, WANG Yan, ZHANG Qingsheng
    2025, 42(10): 1686-1690. DOI: 10.13748/j.cnki.issn1007-7693.20242401
    CSTR: 1
    Abstract PDF
    Study on the Influencing Factors of Drug Quality and Safety Risk Identification for Chinese Drug Inspectors—A Model Construction Based on Grounded Theory
    HU Di, LIAO Ping, LI Sang, CHEN Yuwen
    2025, 42(10): 1691-1697. DOI: 10.13748/j.cnki.issn1007-7693.20241141
    Abstract PDF
    Analysis of the Use of Breakthrough Therapy Program in China from 2020 to 2024
    YU Ting, CHEN Jialing, ZHU Xingyue
    2025, 42(10): 1698-1703. DOI: 10.13748/j.cnki.issn1007-7693.20242523
    Abstract PDF
    Current Status and Recommendations for Proficiency Testing Activities in China's Drug Testing Field: Based on the Scope of PTP Accreditation Capability
    LIU Yadan, WANG Di, CHANG Yan, LI Rui
    2025, 42(10): 1704-1710. DOI: 10.13748/j.cnki.issn1007-7693.20250115
    CSTR: 1
    Abstract PDF
    Research on the Practical Dilemma of Legal Risk Prevention and Control of Chinese Herbal Medicine Internet Operation and Its Regulation Path
    WANG Xiaocao, YUE Yuanlei
    2025, 42(10): 1711-1719. DOI: 10.13748/j.cnki.issn1007-7693.20250324
    CSTR: 免
    Abstract PDF
    Study on Residents' Willingness and Influencing Factors to Migrate from Offline to Online Channels for Drug Purchasing Channels: Taking Beijing as an Example
    LI Xiaopeng, WU Zijing, CHEN Qiao, WANG Yuwei
    2025, 42(10): 1720-1727. DOI: 10.13748/j.cnki.issn1007-7693.20250432
    CSTR: 1
    Abstract PDF
    Research on the Standardization of Traditional Chinese Medicine Decoction Service in Medical Institutions
    ZHOU Xinyue, TIAN Kan, YU Xiaoyong
    2025, 42(10): 1728-1732. DOI: 10.13748/j.cnki.issn1007-7693.20250431
    CSTR: 1
    Abstract PDF
    Research on Clinical Contexts, Models and Decision Aids in Shared Decision-making Guided by Rational Use of Medicines
    XIN Wanting, YAN Jianzhou
    2025, 42(10): 1733-1739. DOI: 10.13748/j.cnki.issn1007-7693.20250448
    CSTR: 1
    Abstract PDF
    Analysis and Implications of the Current Situation of the Drug Vigilance System in Medical Institutions of Guangdong Province Based on NVivo
    HE Bing, XIONG Huiyu, ZHU Feng, CAI Fei, LIU Zhen, HUANG Yan, LIU Zuoren
    2025, 42(10): 1740-1746. DOI: 10.13748/j.cnki.issn1007-7693.20250336
    CSTR: 1
    Abstract PDF
    Hot Spots and Implications of Ageing Research on Drug Package Inserts in International Perspective
    HE Yufang, LYU Kan, WU Xinliang, WANG Xinyu, ZHAO Qian, XIA Fang
    2025, 42(10): 1747-1753. DOI: 10.13748/j.cnki.issn1007-7693.20250516
    CSTR: 未缴费
    Abstract PDF
    Analysis on the Utilization of Hypoglycemic Drugs Based on National Drug Usage Monitoring Data
    ZENG Dayong, WANG Feiyu, LIN Rongfang, LIN Cuihong, HUANG Pinfang
    2025, 42(10): 1754-1761. DOI: 10.13748/j.cnki.issn1007-7693.20241205
    Abstract PDF
    Evaluation of Telepharmacy Services Policies in Jilin Province
    HE Yufang, JIA Ruoyao, DUAN Wenjing, GONG Zhen, XIA Fang
    2025, 42(10): 1762-1767. DOI: 10.13748/j.cnki.issn1007-7693.20250521
    CSTR: 未缴费
    Abstract PDF
    Study on the Integrated Development of Biomedical Industry in Yangtze River Delta Based on the "Four Chains" Integration Mechanism Model
    GU Yang, LI Han, NIU Yuxin, ZHAO Luyu, ZHUANG Qian
    2025, 42(10): 1768-1773. DOI: 10.13748/j.cnki.issn1007-7693.20241536
    CSTR: 1
    Abstract PDF
    Research on Countermeasures for Integration of Pharmaceutical Manufacturing Industry Chain and Innovation Chain: Based on the Comparative Perspective of Yangtze River Delta and Germany
    DONG Ying, XIANG Ziwei
    2025, 42(10): 1774-1783. DOI: 10.13748/j.cnki.issn1007-7693.20241173
    Abstract PDF
    Bibliometric-based Analysis of the Current Research Status and Hotspots of AI Applications in the Medical Field
    ZHANG Junlin, LI Jun, LAN Yafei, MAO Ningying
    2025, 42(10): 1784-1792. DOI: 10.13748/j.cnki.issn1007-7693.20250483
    CSTR: 1
    Abstract PDF
    Research on the Configuration Path of Human Capital to the Digital Transformation of Pharmaceutical Manufacturing Industry
    ZHANG Haixin, WANG Shuling
    2025, 42(10): 1793-1798. DOI: 10.13748/j.cnki.issn1007-7693.20243076
    CSTR: 1
    Abstract PDF
    Analysis and Implications of the Introduction of the Continuous Professional Development Model into Continuing Education for Licensed Pharmacists in the United States
    RONG Zhihuan, ZHANG Xinping
    2025, 42(10): 1799-1806. DOI: 10.13748/j.cnki.issn1007-7693.20250387
    CSTR: 1
    Abstract PDF